Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

261 Views

226. Antimicrobial Novel Agents: Saturday, 12:15 - 1:30 p.m.

Poster Session: Antimicrobial Novel Agents

(2156) The Rational Design of SER-147: a Cultivated Microbial Consortium to Restore Colonization Resistance and Mitigate Infection in Chronic Liver Disease

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Jenna I. Wurster, PhD (she/her/hers)

Scientist, Computational Microbiome Sciences, Research & Development
Seres Therapeutics
Cambridge, Massachusetts, United States
TS

Tim Straub, MS

Seres Therapeutics, Cambridge, MA
Cambridge, Massachusetts, United States
EO

Edward J. O'Brien, PhD

Group Leader, Computational Microbiome Sciences
Seres Therapeutics
Cambridge, Massachusetts, United States
NE

Nathaniel J. Ennis, n/a

Seres Therapeutics
Cambridge, Massachusetts, United States
MM

Melissa Mayol, n/a

Seres Therapeutics
Cambridge, Massachusetts, United States
JB

Jessica Brown, n/a

Seres Therapeutics
Cambridge, Massachusetts, United States
MV

Marin Vulić, PhD

Senior Principal Scientist
Seres Therapeutics
Cambridge, Massachusetts, United States
NB

Nicholas Beauchemin, n/a

Seres Therapeutics
Cambridge, Massachusetts, United States
Elizabeth Halvorsen, PhD

Director
Seres Therapeutics
Cambridge, MA, United States